Assessing the current state of public-health-related outcomes in opioid dependence across Europe: Data from the EQUATOR analysis

Heroin Addiction and Related Clinical Problems

Volumn 14, Issue 4, 2012, Pages 51-64

  Stöver, Heino ^a  

^a FRANKFURT UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

Comorbidities; Diversion; Employment; Illicit drug use; Prison

Indexed keywords

ARTICLE; COMMUNITY REINTEGRATION; COMORBIDITY; EMPLOYMENT STATUS; EUROPE; HARM REDUCTION; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE DRUG ABUSE; OPIATE ADDICTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; PUBLIC HEALTH;

EID: 84871638773     PISSN: 15921638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ALHO H., SINCLAIR D., VUORI E., HOLOPAINEN A. (2007): Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend 88: 75-78.
2. AUSTRALIAN GOVERNMENT DEPARTMENT OF HEALTH AND AGEING. (2011): Australian national drugs strategy 2010-2015: a framework for action on alcohol, tobacco, illegal and other drugs. Last accessed 25 October 2012 at www.health.gov.au.
3. CARRIERI M.P., VLAHOV D., DELLAMONICA P., GALLAIS H., LEPEU G., SPIRE B., OBADIA Y. (2000): Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group. Drug Alcohol Depend 60: 51-54.
4. COX W.M. (2002): Evaluation of a shared-care program for methadone treatment of drug abuse: an international perspective. J Drug Issues 32: 1115-1124.
5. DEPARTMENT OF COMMUNITY RURAL AND GAELTACHT AFFAIRS DEPARTMENT OF HEALTH (IRELAND). (2009): National Drugs Strategy (interim) 2009-2016. Last accessed 25 October 2012 at www.drugsandalcohol.ie.
6. DUFFY P., BALDWIN H. (2012): The nature of methadone diversion in England: a Merseyside case study. Harm Reduct J 9: 3.
7. EMCDDA. (2009): Polydrug use: patterns and responses. Last accessed 30 October 2012 at www.emcdda.europa.eu.
8. EMCDDA. (2011): 2011 Annual report on the state of the drugs problem in Europe. Last accessed 30 October 2012 at www.emcdda.europa.eu.
9. EMCDDA. (2011): Data: statistical bulletin 2011. Last accessed 30 October 2012 at www.emcdda.europa.eu.
10. EMCDDA. (2012): Social reintegration and employment: evidence and interventions for drug users in treatment. Last accessed 25 October 2012 at www.emcdda.europa.eu.
11. EMCDDA. (2012): Statistical bulletin 2012. Last accessed 10 August 2012 at www.emcdda.europa.eu.
12. EUROPEAN COMMISSION. (2012): Euro area unemployment rate at 11.3%. Eurostat Euroindicators News release 124. Last accessed 31 August 2012 at epp. eurostat.ec.europa.eu.
13. EXECUTIVE OFFICE OF THE PRESIDENT OF THE UNITED STATES. (2012): National drug control strategy 2012. Last accessed 2 August 2012 at www.whitehouse.gov.
14. FISCHER G., STÖVER H. (2012): Assessing the current state of opioid-dependence treatment across Europe: methodology of the European Quality Audit of Opioid Treatment (EQUATOR) project. Heroin Addict Relat Clin Probl 14: 5-70.
15. GRUBER V.A., Mccance-Katz E.F. (2010): Methadone, buprenorphine, and street drug interactions with antiretroviral medications. Curr HIV /AIDS Rep 7: 152-160.
16. HEDRICH D., ALVES P., FARRELL M., STOVER H., MOLLER L., MAYET S. (2012): The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction 107: 501-517.
17. Hm Government. (2010): Drug strategy 2010: Reducing demand, restricting supply, building recovery: supporting people to live a drug free life. Last accessed 15 March 2012 at www.homeoffice.gov.uk.
18. LANGENDAM M.W., VAN BRUSSEL G.H., COUTINHO R.A., VAN AMEIJDEN E.J. (2001): The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health 91: 774-780.
19. LARNEY S., TOSON B., BURNS L., and DOLAN K. (2011): Opioid substitution treatment in prison and postrelease: Effects on criminal recidivism and mortality. Last accessed 25 October 2012 at http://www.ndlerf.gov.au.
20. LINTZERIS N., MITCHELL T.B., BOND A., NESTOR L., STRANG J. (2006): Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients. J Clin Psychopharmacol 26: 274-283.
21. LUCAS G.M., CHAUDHRY A., HSU J., WOODSON T., LAU B., OLSEN Y., KERULY J.C., FIELLIN D.A., FINKELSTEIN R., Barditch-Crovo P., COOK K., MOORE R.D. (2010): Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial. Ann Intern Med 152: 704-711.
22. MARLOWE D.B. (2003): Integrating Substance Abuse Treatment and Criminal Justice Supervision. Science & Practice Perspectives 2: 4-14.
23. ORMAN J.S., KEATING G.M. (2009): Buprenorphine/ naloxone: a review of its use in the treatment of opioid dependence. Drugs 69: 577-607.
24. REISSNER V., KOKKEVI A., SCHIFANO F., ROOM R., STORBJORK J., STOHLER R., DIFURIA L., REHM J., GEYER M., HOLSCHER F., SCHERBAUM N. (2012): Differences in drug consumption, comorbidity and health service use of opioid addicts across six European urban regions (TREAT-project). Eur Psychiatry 27: 455-462.
25. Scottish Government. (2012): The Road to Recovery: A New Approach to Tackling Scotland's Drug Problem. Last accessed 7 June 2012 at www.scotland.gov.uk.
26. STOVER H., MICHELS I.I. (2010): Drug use and opioid substitution treatment for prisoners. Harm Reduct J 7: 17.
27. SULLIVAN L.E., MOORE B.A., CHAWARSKI M.C., PANTALON M.V., BARRY D., O'CONNOR P.G., SCHOTTENFELD R.S., FIELLIN D.A. (2008): Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. J Subst Abuse Treat 35: 87-92.
28. WELSH ASSEMBLY GOVERNMENT. (2012): Working Together to Reduce Harm The Substance Misuse Strategy for Wales 2008-2018. Last accessed 7 June 2012 at www.wales.gov.uk.
29. WODAK A., MCLEOD L. (2008): The role of harm reduction in controlling HIV among injecting drug users. AIDS 22 Suppl 2: S81-S92.
30. WORLD HEALTH ORGANIZATION. (2009): Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Last accessed 26 October 2012 at www.who.int.